Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification
Journal of Proteome Research · 2024
DOI: 10.1021/acs.jproteome.4c00624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Wujie Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ningbo No. 2 Hospital, No. 41 Northwest Street Haishu District, Ningbo, Zhejiang 315010, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Proteomics, Fibrinogen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Hwa Mei Research Foundation of Ningbo Second Hospital.
Abstract (Originalsprache)
Early and accurate diagnosis of gastric cancer (GC) is essential for reducing mortality and improving patient well-being. However, methods for the early diagnosis of GC are still lacking. In this study, by isobaric tagging for relative and absolute quantitation (iTRAQ), we identified 336 proteins that overlapped among the upregulated differentially expressed proteins (DEPs) in early gastric cancer (EGC) versus progressive gastric cancer (PGC), upregulated DEPs in EGC versus nongastric cancer (NGC), and nonsignificant proteins in EGC versus NGC. These DEPs were involved primarily in the neutrophil-related immune response. Network analysis of proteins and pathways revealed that fibrinogen α (FGA), β (FGB), and γ (FGG) are candidates for distinguishing EGC. Furthermore, parallel reaction monitoring (PRM), immunohistochemistry (IHC), and Western blot (WB) assays of clinical samples confirmed that, compared with that in PGC and NGC, only FGG was uniquely and significantly upregulated in the gastric mucosa of EGC. Our results demonstrated that FGG in the gastric mucosa could be a novel biomarker to diagnose EGC patients via endoscopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Ningbo No. 2 Hospital, No. 41 Northwest Street Haishu District, Ningbo, Zhejiang 315010, China.
ORCID-Profile: Hanxiao Tu
Förderung
- Hwa Mei Research Foundation of Ningbo Second Hospital
Zitieren
APA
Chen, W., Ye, Q., Zhang, B., Ma, Z., & Tu, H. (2024). Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00624
Vancouver
Chen W, Ye Q, Zhang B, Ma Z, Tu H. Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00624
BibTeX
@article{Chen2024,
author = {Chen, Wujie and Ye, Qihua and Zhang, Biying and Ma, Zhenhua and Tu, Hanxiao},
title = {Identification of FGG as a Biomarker in Early Gastric Cancer via Tissue Proteomics and Clinical Verification},
journal = {Journal of Proteome Research},
year = {2024},
doi = {10.1021/acs.jproteome.4c00624}
}
EUVIMED